First-Trimester and Second-Trimester Maternal Serum Biomarkers As Predictors of Placental Abruption

Overview

Journal Obstet Gynecol

Specialty Gynecology & Obstetrics

Date 2017 Feb 9

PMID 28178056

Citations 9

Authors

Cande V Ananth

Ronald J Wapner

Srinidhi Ananth

Mary E DAlton

Anthony M Vintzileos

Affiliations

Soon will be listed here.

Abstract

Objective: We hypothesized that the origins of abruption may extend to the stages of placental implantation; however, there are no reliable markers to predict its development. Based on this hypothesis, we sought to evaluate whether first-trimester and second-trimester serum analytes predict placental abruption.

Methods: We performed a secondary analysis of data of 35,307 women (250 abruption cases) enrolled in the First and Second Trimester Evaluation of Risk cohort (1999-2003), a multicenter, prospective cohort study. Percentiles (based on multiples of the median) of first-trimester (pregnancy-associated plasma protein A and total and free β-hCG) and second-trimester (maternal serum alpha-fetoprotein, unconjugated estriol, and inhibin-A) serum analytes were examined in relation to abruption. Associations are based on risk ratio (RR) and 95% confidence interval (CI).

Results: Women with an abnormally low pregnancy-associated plasma protein A (fifth percentile or less) were at increased risk of abruption compared with those without abruption (9.6% compared with 5.3%; RR 1.9, 95% CI, 1.2-2.8). Maternal serum alpha-fetoprotein 95th percentile or greater was more common among abruption (9.6%) than nonabruption (5.1%) pregnancies (RR 1.9, 95% CI 1.3-3.0). Inhibin-A fifth percentile or less (8.0% compared with 5.1%; RR 1.8, 95% CI 1.1-2.9), and 95th percentile or greater (9.6% compared with 5.0%; RR 2.0, 95% CI 1.3-3.1) were associated with abruption. Women with all three abnormal pregnancy-associated plasma protein A, maternal serum alpha-fetoprotein, and inhibin-A analytes were at 8.8-fold (95% CI 2.3-34.3) risk of abruption. No associations were seen with other analytes.

Conclusion: These data provide support for our hypothesis that the origins of placental abruption may extend to the early stages of pregnancy.

Citing Articles

Effect of subchorionic hematoma on first-trimester maternal serum free β-hCG and PAPP-A levels.

Akay A, Akdas Reis Y, Sahin B, Oncu A, Obut M, Iskender C Rev Bras Ginecol Obstet. 2024; 46.

PMID: 39176201 PMC: 11341181. DOI: 10.61622/rbgo/2024rbgo66.

as a Culprit of Primary Uterine Rupture Alongside Abruptio Placentae: A Case Report.

Rahman L, Praharsini K, Januajie A, Anwar R Int Med Case Rep J. 2024; 17:51-55.

PMID: 38283596 PMC: 10812690. DOI: 10.2147/IMCRJ.S442687.

Study on the Effect of B-Ultrasound NT Scan in Early Pregnancy Combined with Serum Screening in Early and Middle Pregnancy for Down Syndrome.

Li L, Ma C, Sun L Comput Math Methods Med. 2022; 2022:7517112.

PMID: 36277024 PMC: 9584664. DOI: 10.1155/2022/7517112.

Association of Early Beta Human Chorionic Gonadotropin With Ischemic Placental Disease in Singleton Pregnancies After In Vitro Fertilization.

Shah J, Modest A, Hacker M, Resetkova N, Dodge L Cureus. 2022; 14(8):e28117.

PMID: 36134080 PMC: 9481264. DOI: 10.7759/cureus.28117.

Placental Syndromes-A New Paradigm in Perinatology.

Kosinska-Kaczynska K Int J Environ Res Public Health. 2022; 19(12).

PMID: 35742640 PMC: 9224387. DOI: 10.3390/ijerph19127392.

References

Krantz D, Goetzl L, Simpson J, Thom E, Zachary J, Hallahan T . Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes. Am J Obstet Gynecol. 2004; 191(4):1452-8. DOI: 10.1016/j.ajog.2004.05.068. View

Williams M, Hickok D, Zingheim R, Luthy D, Kimelman J, Nyberg D . Elevated maternal serum alpha-fetoprotein levels and midtrimester placental abnormalities in relation to subsequent adverse pregnancy outcomes. Am J Obstet Gynecol. 1992; 167(4 Pt 1):1032-7. DOI: 10.1016/s0002-9378(12)80033-0. View

Chandra S, Scott H, Dodds L, Watts C, Blight C, Van den Hof M . Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes. Am J Obstet Gynecol. 2003; 189(3):775-81. DOI: 10.1067/s0002-9378(03)00769-5. View

Lambert-Messerlian G, Eklund E, Malone F, Palomaki G, Canick J, DAlton M . Stability of first- and second-trimester serum markers after storage and shipment. Prenat Diagn. 2005; 26(1):17-21. DOI: 10.1002/pd.1326. View

DeRoo L, Skjaerven R, Wilcox A, Klungsoyr K, Wikstrom A, Morken N . Placental abruption and long-term maternal cardiovascular disease mortality: a population-based registry study in Norway and Sweden. Eur J Epidemiol. 2015; 31(5):501-11. PMC: 4901083. DOI: 10.1007/s10654-015-0067-9. View

Tikkanen M, Hamalainen E, Nuutila M, Paavonen J, Ylikorkala O, Hiilesmaa V . Elevated maternal second-trimester serum alpha-fetoprotein as a risk factor for placental abruption. Prenat Diagn. 2007; 27(3):240-3. DOI: 10.1002/pd.1654. View

Hadlock F, Shah Y, Kanon D, Lindsey J . Fetal crown-rump length: reevaluation of relation to menstrual age (5-18 weeks) with high-resolution real-time US. Radiology. 1992; 182(2):501-5. DOI: 10.1148/radiology.182.2.1732970. View

Muttukrishna S, George L, Fowler P, Groome N, Knight P . Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy. Clin Endocrinol (Oxf). 1995; 42(4):391-7. DOI: 10.1111/j.1365-2265.1995.tb02648.x. View

Spong C, Ghidini A, Walker C, OSSANDON M, Pezzullo J . Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia. Am J Obstet Gynecol. 1997; 177(5):1085-7. DOI: 10.1016/s0002-9378(97)70019-x. View

10.

Ananth C, Berkowitz G, Savitz D, Lapinski R . Placental abruption and adverse perinatal outcomes. JAMA. 1999; 282(17):1646-51. DOI: 10.1001/jama.282.17.1646. View

11.

Ananth C, Wilcox A . Placental abruption and perinatal mortality in the United States. Am J Epidemiol. 2001; 153(4):332-7. DOI: 10.1093/aje/153.4.332. View

12.

Ananth C, Oyelese Y, Prasad V, Getahun D, Smulian J . Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions. Eur J Obstet Gynecol Reprod Biol. 2006; 128(1-2):15-21. DOI: 10.1016/j.ejogrb.2006.01.016. View

13.

Cnattingius S, Mills J, Yuen J, Eriksson O, Salonen H . The paradoxical effect of smoking in preeclamptic pregnancies: smoking reduces the incidence but increases the rates of perinatal mortality, abruptio placentae, and intrauterine growth restriction. Am J Obstet Gynecol. 1997; 177(1):156-61. DOI: 10.1016/s0002-9378(97)70455-1. View

14.

Ranta J, Raatikainen K, Romppanen J, Pulkki K, Heinonen S . Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruption. Eur J Obstet Gynecol Reprod Biol. 2011; 157(1):48-52. DOI: 10.1016/j.ejogrb.2011.03.004. View

15.

Pilalis A, Souka A, Antsaklis P, Daskalakis G, Papantoniou N, Mesogitis S . Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation. Ultrasound Obstet Gynecol. 2007; 29(2):135-40. DOI: 10.1002/uog.3881. View

16.

Ananth C, Vintzileos A . Maternal-fetal conditions necessitating a medical intervention resulting in preterm birth. Am J Obstet Gynecol. 2006; 195(6):1557-63. DOI: 10.1016/j.ajog.2006.05.021. View

17.

Ananth C, Smulian J, Vintzileos A . Ischemic placental disease: maternal versus fetal clinical presentations by gestational age. J Matern Fetal Neonatal Med. 2009; 23(8):887-93. DOI: 10.3109/14767050903334885. View

18.

Smith G, Crossley J, Aitken D, Pell J, Cameron A, Connor J . First-trimester placentation and the risk of antepartum stillbirth. JAMA. 2004; 292(18):2249-54. DOI: 10.1001/jama.292.18.2249. View

19.

Canick J, Lambert-Messerlian G, Palomaki G, Neveux L, Malone F, Ball R . Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol. 2006; 108(5):1192-9. DOI: 10.1097/01.AOG.0000241095.19638.f2. View

20.

Blumenfeld Y, Baer R, Druzin M, El-Sayed Y, Lyell D, Faucett A . Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption. Am J Obstet Gynecol. 2014; 211(2):144.e1-9. DOI: 10.1016/j.ajog.2014.03.027. View